IP Library Granted Patent US 8,871,916
Granted Patent B2
US 8,871,916 · App. 13/715,842 · Granted Oct 28, 2014

Diaryl phosphine compounds

Inventors: Ronald Thaddeus Raines (Madison, WI); Eddie Leonard Myers (Munich, DE)
Assignee: Wisconsin Alumni Research Foundation
C07C245/18C07C247/12C07C271/22C07F9/5022C07F9/5325C07C2103/24C07F9/5721C07C251/00C07C247/10C07D223/16C07C2101/14C07C2103/18C07F9/28C07C247/14C07C245/12
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 8,871,916
App. No.
13/715,842
Granted
Oct 28, 2014
Kind
B2
Abstract

A method for making diazo-compounds, diazonium salts thereof and other protected forms of these compounds. Diazo-compounds are prepared by reaction of a tertiary phosphine reagent carrying a reactive carbonyl group with an azide. The reaction can also generate an acyl triazene which can be converted thermally or by addition of base to form the diazo-compound or the acyl triazene can be isolated. The method is particularly useful for conversion of azides carrying one or more electron withdrawing groups to diazo-compounds. The method can be carried out in aqueous medium under mild conditions and is particularly useful for conversion of azido sugars to diazo-compounds and diazonium salts thereof under physiological conditions. Tertiary phosphine reagents, particularly those that are water-soluble, and precursors for preparation of the reagents are provided.

Claims (21)

1. The tertiary phosphine of formula:

wherein:

n is an integer ranging from 1-5 inclusive;

—O—R 5 is:

(1) an —ON(R 7 ) 2 group, an —O—NR 7 —CO—R 7 group or an —O—N(COR 7 )—COR 7 group, where each R 7 is an optionally substituted alkyl or aryl, or where the two R 7 groups together form an optionally substituted 5-8 member heterocyclic ring having one or more heteroatoms or —CO— groups or both in the ring;

(2) a phenyloxy group substituted with one or more halogens, hydroxy, nitro, alkyl, alkenyl, alkynyl, aryl, halogenated alkyl, hydroxy-substituted alkyl, amino-substituted alkyl, cyano, isocyano, thiocyano isothiocyano —SO 2 —SO 3 R, —N(R) 2 , —COR, —COOR, —CON(R) 2 , —NR—CO—NR—, —CO—SR, —OR, or —SR, where each R, independently, is hydrogen, alkyl, halogenated alkyl, alkenyl, alkynyl, aryl, halogenated aryl, heteroaryl, or heterocyclic groups, or two R together form a 5-8 member optionally substituted heterocyclic ring containing one or more heteroatoms, optionally one or more —CO— groups or both;

(3) —O—R 5 where R 5 is an optionally substituted heterocylic or heteroaromatic group; or

(4) —O—SO 2 —O—R S where R S is halogen, optionally substituted alkyl, optionally substituted aryl, optionally substituted phenyl, halogenated alkyl, halogenated aryl, halogenated phenyl, fluorinated alkyl, fluorinated aryl, fluorinated phenyl, unsubstituted alkyl, unsubstituted phenyl, methyl, ethyl, —CF 3 , or —C 4 F 9 ; and

Y 1 and Y 2 are alkoxyalkyl groups.

2. The phosphine of claim 1 wherein R 5 is a nitro- or halogen-substituted phenyl group.

3. The phosphine of claim 1 wherein R 5 is a pentafluorophenyl, a 2,4,6-triclorophenyl or a 4-nitrophenyl group.

4. The phosphine of claim 1 wherein the alkoxyalkyl groups have from 2 to 10 carbon atoms.

5. The phosphine of claim 1 wherein the alkoxyalkyl groups are those which have formula: —[(CH 2 )a-O-]b-CH 3 , where a is 1-10 and b is 1-6.

6. The phosphine of claim 5 wherein —R 5 is a 4-nitrophenyl group or an N-hydroxy succinimide.

7. The phosphine of claim 5 wherein —R 5 is a 4-nitrophenyl group.

8. The phosphine of claim 1 which is linked to a solid.

9. The phosphine of claim 1 wherein —O—R 5 is a phenyloxy group substituted with one or more halogens, hydroxy, nitro, alkyl, alkenyl, alkynyl, aryl, halogenated alkyl, hydroxy-substituted alkyl, amino-substituted alkyl, cyano, isocyano, thiocyano, isothiocyano, —SO 2 , —SO 3 R, —N(R) 2 , —COR, —COOR, —CON(R) 2 , —NR—CO—NR—, —CO—SR, —OR, or —SR, where each R, independently, is hydrogen, alkyl, halogenated alkyl, alkenyl, alkynyl, aryl, halogenated aryl, heteroaryl, or heterocyclic groups, or two R together form a 5-8 member optionally substituted heterocyclic ring containing one or more heteroatoms, optionally one or more —CO— groups or both.

10. The phosphine of claim 1 wherein —O—R 5 is a phenyloxy group substituted with a nitro group.

11. The phosphine of claim 1 wherein —R 5 is a 4-nitrophenyl group or an N-hydroxy succinimide.

12. The phosphine of claim 1 wherein —R 5 is a 4-nitrophenyl group.

13. The phosphine of claim 1 wherein the alkoxyalkyl groups have from 3 to 6 carbon atoms.

Assignments (1)
CONFIRMATORY LICENSE Recorded May 8, 2013
From: WISCONSIN ALUMNI RESEARCH FOUNDATION
To: NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT
Reel/Frame 030373/0186 →
Continuity (3)
Continuation 12620567 · Nov 17, 2009
Provisional Application 61115474 · Nov 17, 2008
Related Publication 20130203974A1 · Aug 8, 2013